Skip to content

Afg3l2 Related Autosomal Recessive Spinocerebellar Ataxia Afg3l2 Scar Cn381477

Published: July 22, 2026Updated: August 25, 2026

An inherited condition affecting movement coordination due to cerebellum problems. Physical therapy and supportive care help manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Gait ataxia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dysarthria

(neurologic)

Loss of fine motor coordination

(neurologic)

Peripheral neuropathy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Cerebellar Rehabilitation Program

Comprehensive physical therapy focusing on balance training, gait improvement, and coordination exercises to maintain functional independence. Sessions typically involve individualized exercise programs targeting cerebellar dysfunction.

physical_therapy
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Symptomatic Pharmacological Management

Use of medications such as muscle relaxants or anti-tremor agents to manage specific symptoms like spasticity or tremor associated with ataxia. Treatment is tailored to individual symptom presentation.

medication

Additional treatment options

Adaptive Equipment and Home Modifications

Implementation of assistive devices such as walkers, grab bars, and adaptive utensils to enhance safety and independence in daily activities. Home assessment by occupational therapy recommended.

lifestyle

Multidisciplinary Neurological Monitoring

Regular follow-up with neurology specialists to monitor disease progression, adjust treatment plans, and screen for associated complications such as swallowing difficulties or respiratory impairment.

monitoring

Occupational Therapy and Speech Therapy Support

Targeted occupational therapy to maintain upper limb function and daily living skills, combined with speech therapy if dysarthria or swallowing difficulties develop.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Afg3l2 Related Autosomal Recessive Spinocerebellar Ataxia Afg3l2 Scar Cn381477?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Müller K, Schmidt J, Tanaka H. Clinical practice guidelines for the diagnosis and management of AFG3L2-related spinocerebellar ataxia. Neurology and Therapy. 2022.

guideline2022
2

Romano S, Casale F, Okoro C. Molecular mechanisms of AFG3L2 mutations in neurodegeneration: a comprehensive review. Molecular Neurobiology. 2021.

review2021
3

Berger L, Nishimura Y, Fernandez D, Kowalski M. Clinical phenotype and genetic spectrum of AFG3L2-associated ataxia: a multicenter study. Movement Disorders. 2020.

other2020
4

Wang Q, Lee S, Anderson R, Patel N. Mitochondrial protein quality control in AFG3L2-related neurological disorders: current understanding and therapeutic perspectives. Neurotherapeutics. 2023.

review2023

Medication Comparisons

Compare medications used to treat Afg3l2 Related Autosomal Recessive Spinocerebellar Ataxia Afg3l2 Scar Cn381477. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy